InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.570 0.01 (1.72%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$197 Final Director's Interest Notice - JD 21 Aug 2026 10:45AM $0.575 $0.570 fallen by 0.87%
$197 Results of Annual General Meeting 19 Aug 2026 2:33PM $0.575 $0.570 fallen by 0.87%
$197 CEO Presentation - AGM 19 Aug 2026 8:51AM $0.580 $0.570 fallen by 1.72%
$197 Chairman's Address - AGM 19 Aug 2026 8:44AM $0.580 $0.570 fallen by 1.72%
$197 Notification of cessation of securities - ARX 12 Aug 2026 9:50AM $0.605 $0.570 fallen by 5.79%
$197 Notification regarding unquoted securities - ARX 12 Aug 2026 9:50AM $0.605 $0.570 fallen by 5.79%
$197 Change in substantial shareholding from AEF 7 Aug 2026 9:33AM $0.565 $0.570 risen by 0.88%
$197 Notification regarding unquoted securities - ARX 28 Jul 2026 10:53AM $0.570 $0.570 fallen by 0%
$197 Commercial Leadership Appointments 28 Jul 2026 9:30AM $0.580 $0.570 fallen by 1.72%
$197 Notice of Annual General Meeting/Proxy Form 24 Jul 2026 3:49PM $0.560 $0.570 risen by 1.79%
$197 Notification of cessation of securities - ARX 14 Jul 2026 10:15AM $0.575 $0.570 fallen by 0.87%
$197 Symphony - Outpatient Reimbursement Update 14 Jul 2026 9:56AM $0.585 $0.570 fallen by 2.56%
$197 Resignation of CFO and Joint Company Secretary 9 Jul 2026 4:22PM $0.585 $0.570 fallen by 2.56%
$197 Appendix 4G and Corporate Governance Statement 30 Jun 2026 11:48AM $0.590 $0.570 fallen by 3.39%
$197 Annual Report to Shareholders 30 Jun 2026 11:43AM $0.590 $0.570 fallen by 3.39%
$197 Change of Director's Interest Notice - JD 29 Jun 2026 10:30AM $0.595 $0.570 fallen by 4.20%
$197 Notice of AGM Date and Director Nomination Closing Date 24 Jun 2026 9:01AM $0.600 $0.570 fallen by 5%
$197 Change in substantial holding 27 May 2026 12:23PM $0.625 $0.570 fallen by 8.80%
$197 FY26 Full Year Results Presentation - Correction 26 May 2026 5:03PM $0.620 $0.570 fallen by 8.06%
$197 FY26 Full Year Results Presentation 26 May 2026 8:51AM $0.620 $0.570 fallen by 8.06%
$197 FY26 Appendix 4E and Full Year Results 26 May 2026 8:48AM $0.620 $0.570 fallen by 8.06%
$197 Notification of Full Year Results Webinar 19 May 2026 8:59AM $0.600 $0.570 fallen by 5%
$197 ARX FY26 Preliminary Results 30 Apr 2026 8:24AM $0.550 $0.570 risen by 3.64%
$197 Application for quotation of securities - ARX 10 Apr 2026 3:51PM $0.530 $0.570 risen by 7.55%
$197 Notification of cessation of securities - ARX 9 Apr 2026 12:34PM $0.530 $0.570 risen by 7.55%

1 - 25 of 762 results

Page 1 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.